SCHEMBL4697479

SCHEMBL4697479

CCOC(=O)On1c(=O)[nH]c2cccc(OC)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HSD17B10 Q99714 2/20 0.42
DAO P14920 2/20 0.40
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
PLIN1 O60240 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
PLIN5 Q00G26 1/20 0.39
KMT2A Q03164 1/20 0.39
ABHD5 Q8WTS1 1/20 0.39
ADORA3 P0DMS8 2/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1858707 0.81 KDM4E (0.47) KDM4EALDH1A1HSD17B10DAOMAPT
SCHEMBL13015476 0.70 CYP19A1 (0.47) KDM4EALDH1A1HSD17B10DAOMAPT
SCHEMBL30284065 0.69 ALDH1A1 (0.58) KDM4EALDH1A1HSD17B10DAOMAPT
SCHEMBL28738068 0.67 LMNA (0.45) KDM4EALDH1A1DAOMAPTMEN1
SCHEMBL7550891 0.67 HTR7 (0.44) KDM4EALDH1A1DAOMAPTMEN1
SCHEMBL3733140 0.66 DAO (0.38) DAOMEN1KMT2AADORA3GAA
SCHEMBL13015485 0.64 DAO (0.48) KDM4EALDH1A1HSD17B10DAOMAPT
SCHEMBL6890110 0.64 MAPT (0.51) KDM4EALDH1A1MAPTMEN1PLIN1
SCHEMBL23997181 0.63 PRNP (0.53) KDM4EALDH1A1DAOMAPTMEN1
SCHEMBL2311046 0.63 DAO (0.50) KDM4EALDH1A1HSD17B10DAOMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794154-B1 HETEROARYL COMPOUNDS FOR USE AS BETAMIMETICS IN THE TREATMENT OF RESPIRATORY DISEASES BOEHRINGER INGELHEIM INT (DE) 2013-02-27 EP disclosed
EP-1996581-A1 NOVEL ENANTIOMERICALLY PURE BETA-AGONISTS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-12-03 EP disclosed
EP-1986644-A1 DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES Boehringer Ingelheim International GmbH (DE) 2008-11-05 EP disclosed
WO-2007104772-A9 NOVEL ENANTIOMERICALLY PURE BETA-AGONISTS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2007-11-22 WO disclosed
WO-2007104772-A1 NOVEL ENANTIOMERICALLY PURE BETA-AGONISTS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-09-20 WO disclosed
WO-2007093608-A1 DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY TRACT DISEASES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-08-23 WO disclosed
EP-1794154-A1 HETEROARYL COMPOUNDS FOR USE AS BETAMIMETICS IN THE TREATMENT OF RESPIRATORY DISEASES Boehringer Ingelheim International GmbH (DE) 2007-06-13 EP disclosed
WO-2006032627-A1 HETEROARYL COMPOUNDS FOR USE AS BETAMIMETICS IN THE TREATMENT OF RESPIRATORY DISEASES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-03-30 WO disclosed